glp-1 receptor agonists weight loss effectiveness for reduction in people living with obesity but without diabetes: a living benefit–harm modelling study Effect of GLP-1 receptor agonists

However, with increasing clinical evidence supporting their efficacy in weight loss, demand for these drugs in obesity treatment is increasing

Welcome back to our channel

How Optum Rx can help you manage GLP-1/GIP trend Given the complex and evolving nature of this drug class, plan sponsors need a strategic partner with the capabilities to provide options and management strategies to help balance cost and utilization of GLP-1s

While the foundations of a healthy lifestyle will always begin with diet and exercise, and bariatric procedures can be the right choice for patients with the chronic health issues associated with severe obesity, GLP-1 receptor agonists provide another safe, effective, and measured approach

10.1016/j.phrs.2019.104615 Pharmacol